Eckert & Ziegler Strahlen- und Medizintechnik AG
A global provider of isotope technology for medical, scientific, and industrial use.
EUZ | F
Overview
Corporate Details
- ISIN(s):
- DE0005659700
- LEI:
- 391200EUDABLUKXCKG48
- Country:
- Germany
- Address:
- Robert-Rössle-Str. 10, 13125 Berlin
- Website:
- https://www.ezag.com/startseite/
- Sector:
- Manufacturing
Description
Eckert & Ziegler Strahlen- und Medizintechnik AG is a global provider of isotope technology for medical, scientific, and industrial use. The company's core business focuses on cancer therapy, industrial radiometry, and nuclear-medical imaging. It specializes in developing and manufacturing radioactive components and related equipment. Key offerings for the medical sector include products and services for nuclear medicine and radiation therapy, such as radiopharmaceuticals, radiosynthesis and quality control (QC) solutions, and sealed radiation sources. The company also provides essential infrastructure like hot cells and radiation protection solutions, supporting the radiopharmaceutical industry from early development through to commercial production.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2011-01-10 09:54 |
DGAP-DD: Eckert & Ziegler Strahlen- und Medizintechnik AG english
|
English | 1.7 KB | ||
| 2010-12-27 18:07 |
Eckert & Ziegler subsidiary IBt Bebig acquires specialist for medical planning …
|
English | 3.9 KB | ||
| 2010-12-02 13:04 |
DGAP-DD: Eckert & Ziegler Strahlen- und Medizintechnik AG english
|
English | 1.7 KB | ||
| 2010-11-02 07:45 |
Eckert & Ziegler: Annual Net Profit Increases by 48%
|
English | 5.8 KB | ||
| 2010-11-02 00:00 |
Q3 Report 2010
|
German | 737.1 KB | ||
| 2010-10-13 13:50 |
Eckert & Ziegler awards grants to young researchers in nuclear medicine
|
English | 4.0 KB | ||
| 2010-09-21 09:41 |
Eckert & Ziegler Strahlen- und Medizintechnik AG: Technological leap in prostat…
|
English | 4.3 KB | ||
| 2010-08-03 07:45 |
Eckert & Ziegler: Highest quarterly profit in Q2 2010
|
English | 4.8 KB | ||
| 2010-08-03 00:00 |
Q2 Report 2010
|
German | 648.5 KB | ||
| 2010-07-07 10:42 |
Eckert & Ziegler: first patient treated for Brain cancer using IsoSeed(R)
|
English | 3.6 KB | ||
| 2010-06-25 11:47 |
Eckert & Ziegler Becomes Main Supplier to Innovative Leukaemia Drug
|
English | 7.3 KB | ||
| 2010-06-21 14:01 |
Eckert & Ziegler is awarded the Contract for Radiodiagnostics in Gdansk
|
English | 4.0 KB | ||
| 2010-06-17 17:40 |
Eckert & Ziegler sees potential in Breast Cancer Brachytherapy
|
English | 5.7 KB | ||
| 2010-06-01 17:42 |
Eckert & Ziegler: Major Order for Prostate Implants
|
English | 2.7 KB | ||
| 2010-05-21 14:09 | English | 2.0 KB |
Automate Your Workflow. Get a real-time feed of all Eckert & Ziegler Strahlen- und Medizintechnik AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Eckert & Ziegler Strahlen- und Medizintechnik AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Eckert & Ziegler Strahlen- und Medizintechnik AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-30 | Eckert, Dr. Andreas | Supervisory board | Sell | None | 1,526,400.00 EUR |
| 2023-08-30 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | None | 1,526,400.00 EUR |
| 2023-08-11 | Perschmann, Frank | Supervisory board | Buy | None | 16,600.00 EUR |
| 2023-01-13 | NEON Equity AG | Close relation | Buy | None | 2,115.00 EUR |
| 2023-01-12 | Blunck, Dr. Thomas | Board | Sell | None | 57,402.00 EUR |
| 2023-01-12 | Blunck, Dr. Thomas | Board | Sell | None | 32,160.00 EUR |
| 2023-01-11 | Bouterfa, Dr. Hakim | Board | Buy | None | 124,800.00 EUR |
| 2022-12-21 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | None | 1,432,800.00 EUR |
| 2022-12-06 | Maennig, Prof. Dr. Wolfgang | Supervisory board | Buy | None | 72,745.31 EUR |
| 2022-12-05 | Carpio GmbH | Close relation | Buy | None | 73,826.53 EUR |
Peer Companies
